FDA Clears New Spectral CT Platform with AI-Powered Image Reconstruction

Offering rapid AI-enhanced image reconstruction, the Philips Spectral CT Verida system has garnered 510(k) clearance from the Food and Drug Administration (FDA).

Emphasizing enhanced tissue characterization and material differentiation, Philips said the Spectral CT Verida platform allows simultaneous viewing of conventional CT and spectral CT results due to the system’s ability to capture high- and low-energy data in a single acquisition.

Specifically, Philips noted that the Spectral CT Verida system:

• offers reconstruction of 145 images per second;

• enables entire CT exams to appear in less than 30 seconds; and

• facilitates the performance of up to 270 CT exams a day.

“With FDA clearance for Verida, we are bringing the next evolution of spectral CT to more markets,” said Dan Xu, the business leader of CT at Philips. “By combining always-on spectral imaging with AI-powered reconstruction, Verida enables clinicians to see more, first time right, supporting faster, more informed decisions and expanding the role of CT across clinical pathways.”